Synaptotagmin-3 drives AMPA receptor endocytosis, depression of synapse strength, and forgetting.


Journal

Science (New York, N.Y.)
ISSN: 1095-9203
Titre abrégé: Science
Pays: United States
ID NLM: 0404511

Informations de publication

Date de publication:
04 01 2019
Historique:
received: 18 08 2018
accepted: 01 11 2018
pubmed: 14 12 2018
medline: 25 7 2019
entrez: 15 12 2018
Statut: ppublish

Résumé

Forgetting is important. Without it, the relative importance of acquired memories in a changing environment is lost. We discovered that synaptotagmin-3 (Syt3) localizes to postsynaptic endocytic zones and removes AMPA receptors from synaptic plasma membranes in response to stimulation. AMPA receptor internalization, long-term depression (LTD), and decay of long-term potentiation (LTP) of synaptic strength required calcium-sensing by Syt3 and were abolished through Syt3 knockout. In spatial memory tasks, mice in which Syt3 was knocked out learned normally but exhibited a lack of forgetting. Disrupting Syt3:GluA2 binding in a wild-type background mimicked the lack of LTP decay and lack of forgetting, and these effects were occluded in the Syt3 knockout background. Our findings provide evidence for a molecular mechanism in which Syt3 internalizes AMPA receptors to depress synaptic strength and promote forgetting.

Identifiants

pubmed: 30545844
pii: science.aav1483
doi: 10.1126/science.aav1483
pii:
doi:

Substances chimiques

Receptors, AMPA 0
Syt3 protein, mouse 0
Synaptotagmins 134193-27-4
Calcium SY7Q814VUP

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Subventions

Organisme : CIHR
Pays : Canada

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2019 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Auteurs

Ankit Awasthi (A)

Trans-synaptic Signaling Group, European Neuroscience Institute, 37077 Goettingen, Germany.

Binu Ramachandran (B)

Trans-synaptic Signaling Group, European Neuroscience Institute, 37077 Goettingen, Germany.

Saheeb Ahmed (S)

Trans-synaptic Signaling Group, European Neuroscience Institute, 37077 Goettingen, Germany.

Eva Benito (E)

German Center for Neurodegenerative Disease, 37075 Goettingen, Germany.
Department of Psychiatry and Psychotherapy, University Medical Center Goettingen, 37075 Goettingen, Germany.

Yo Shinoda (Y)

Trans-synaptic Signaling Group, European Neuroscience Institute, 37077 Goettingen, Germany.

Noam Nitzan (N)

Trans-synaptic Signaling Group, European Neuroscience Institute, 37077 Goettingen, Germany.

Alina Heukamp (A)

Trans-synaptic Signaling Group, European Neuroscience Institute, 37077 Goettingen, Germany.

Sabine Rannio (S)

Trans-synaptic Signaling Group, European Neuroscience Institute, 37077 Goettingen, Germany.

Henrik Martens (H)

Synaptic Systems GmbH, 37079 Goettingen, Germany.

Jonas Barth (J)

German Center for Neurodegenerative Disease, 37075 Goettingen, Germany.
Department of Psychiatry and Psychotherapy, University Medical Center Goettingen, 37075 Goettingen, Germany.

Katja Burk (K)

Trans-synaptic Signaling Group, European Neuroscience Institute, 37077 Goettingen, Germany.

Yu Tian Wang (YT)

Brain Research Center and Department of Medicine, University of British Columbia, Vancouver, BC V6T2B5, Canada.

Andre Fischer (A)

German Center for Neurodegenerative Disease, 37075 Goettingen, Germany.
Department of Psychiatry and Psychotherapy, University Medical Center Goettingen, 37075 Goettingen, Germany.

Camin Dean (C)

Trans-synaptic Signaling Group, European Neuroscience Institute, 37077 Goettingen, Germany. c.dean@eni-g.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH